Syntenin increases the invasiveness of small cell lung cancer cells by activating p38, AKT, focal adhesion kinase and SP1

Experimental and Molecular Medicine

Volumn 46, Issue 4, 2014, Pages

  Kim, Wook Youn ^a,b   Jang, Ji Young ^a   Jeon, Yoon Kyung ^a   Chung, Doo Hyun ^a   Kim, Young Goo ^a   Kim, Chul Woo ^a  

^a Seoul National University   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

Author keywords

MMP; P38 MAPK; PI3K AKT; Small cell lung cancer; Syntenin

Indexed keywords

FOCAL ADHESION KINASE; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE 14; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SYNTENIN; TRANSCRIPTION FACTOR SP1; MMP14 PROTEIN, HUMAN; MMP2 PROTEIN, HUMAN;

ADVANCED CANCER; ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR SIGNALING; LUNG CANCER CELL LINE; LUNG SMALL CELL CANCER; MELANOMA; METASTASIS; NEUROENDOCRINE TUMOR; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR INVASION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SMALL CELL LUNG CARCINOMA; SP1 TRANSCRIPTION FACTOR; SYNTENINS;

EID: 84902150827     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2014.1     Document Type: Article

References (29)

1. Grootjans JJ, Reekmans G, Ceulemans H, David G. Syntenin-syndecan binding requires syndecan-synteny and the co-operation of both PDZ domains of syntenin. J Biol Chem 2000;275:19933-19941.
2. Sarkar D, Boukerche H, Su ZZ, Fisher PB. mda-9/Syntenin: more than just a simple adaptor protein when it comes to cancer metastasis. Cancer Res 2008;68:3087-3093.
3. Zimmermann P, Tomatis D, Rosas M, Grootjans J, Leenaerts I, Degeest G et al. Characterization of syntenin, a syndecan-binding PDZ protein, as a component of cell adhesion sites and microfilaments. Mol Biol Cell 2001;12:339-350.
4. Grootjans JJ, Zimmermann P, Reekmans G, Smets A, Degeest G, Durr J et al. Syntenin, a PDZ protein that binds syndecan cytoplasmic domains. Proc Natl Acad Sci USA 1997;94:13683-13688.
5. Helmke BM, Polychronidis M, Benner A, Thome M, Arribas J, Deichmann M. Melanoma metastasis is associated with enhanced expression of the syntenin gene. Oncol Rep 2004;12:221-228.
6. Sarkar D, Boukerche H, Su ZZ, Fisher PB. mda-9/syntenin: recent insights into a novel cell signaling and metastasis-associated gene. Pharmacol Ther 2004;104:101-115.
7. Boukerche H, Baril P, Tabone E, Berard F, Sanhadji K, Balme B et al. A new Mr 55, 000 surface protein implicated in melanoma progression: association with a metastatic phenotype. Cancer Res 2000;60:5848-5856.
8. Baril P, Nejjari M, Scoazek JY, Boukerche H. Blocking a novel 55 kDa melanoma-associated cell surface antigen inhibits the development of spontaneous metastases and interactions with frozen lung section. Int J Cancer 2002;99:315-322.
9. Boukerche H, Su ZZ, Emdad L, Baril P, Balme B, Thomas L et al. mda-9/Syntenin: a positive regulator of melanoma metastasis. Cancer Res 2005;65:10901-10911.
10. Koo TH, Lee JJ, Kim EM, Kim KW, Kim HD, Lee JH. Syntenin is overexpressed and promotes cell migration in metastatic human breast and gastric cancer cell lines. Oncogene 2002;21:4080-4088.
11. Meerschaert K, Bruyneel E, De Wever O, Vanloo B, Boucherie C, Bracke M et al. The tandem PDZ domains of syntenin promote cell invasion. Exp Cell Res 2007;313:1790-1804.
12. Boukerche H, Su ZZ, Emdad L, Sarkar D, Fisher PB. mda-9/Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB. Cancer Res 2007;67:1812-1822.
13. Boukerche H, Su ZZ, Prevot C, Sarkar D, Fisher PB. mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src. Proc Natl Acad Sci USA 2008;105:15914-15919.
14. Buttery RC, Rintoul RC, Sethi T. Small cell lung cancer: the importance of the extracellular matrix. Int J Biochem Cell Biol 2004;36:1154-1160.
15. Nicholson SA, Beasley MB, Brambilla E, Hasleton PS, Colby TV, Sheppard MN et al. Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens. Am J Surg Pathol 2002;26:1184-1197.
16. Sethi T, Rintoul RC, Moore SM, MacKinnon AC, Salter D, Choo C et al. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat Med 1999;5:662-668.
17. Fridman R, Giaccone G, Kanemoto T, Martin GR, Gazdar AF, Mulshine JL. Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines. Proc Natl Acad Sci USA 1990;87:6698-6702.
18. Bae IH, Park MJ, Yoon SH, Kang SW, Lee SS, Choi KM et al. Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt, and Sp1. Cancer Res 2006;66:4991-4995.
19. Zelen M. Keynote address on biostatistics and data retrieval. Cancer Chemother Rep 3 1973;4:31-42.
20. Luyten A, Mortier E, Van Campenhout C, Taelman V, Degeest G, Wuytens G et al. The postsynaptic density 95/disc-large/zona occludens protein syntenin directly interacts with frizzled 7 and supports noncanonical Wnt signaling. Mol Biol Cell 2008;19:1594-1604.
21. Overall CM, Lopez-Otin C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2002;2:657-672.
22. Michael M, Babic B, Khokha R, Tsao M, Ho J, Pintilie M et al. Expression and prognostic significance of metalloproteinases and their tissue inhibitors in patients with small-cell lung cancer. J Clin Oncol 1999;17:1802-1808.
23. Damstrup L, Rude Voldborg B, Spang-Thomsen M, Brunner N, Skovgaard Poulsen H. In vitro invasion of small-cell lung cancer cell lines correlates with expression of epidermal growth factor receptor. Br J Cancer 1998;78:631-640.
24. Kawano N, Osawa H, Ito T, Nagashima Y, Hirahara F, Inayama Y et al. Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin (ogen) in lung neoplasms: an immunohistochemical study. Hum Pathol 1997;28:613-622.
25. Savaraj N, Wei Y, Unate H, Liu PM, Wu CJ, Wangpaichitr M et al. Redox regulation of matrix metalloproteinase gene family in small cell lung cancer cells. Free Radic Res 2005;39:373-381.
26. Boukerche H, Aissaoui H, Prevost C, Hirbec H, Das SK, Su ZZ et al. Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB. Oncogene 2010;29:3054-3066.
27. Lee JW, Juliano R. Mitogenic signal transduction by integrin- and growth factor receptor-mediated pathways. Mol Cells 2004;17:188-202.
28. Feldman LE, Shin KC, Natale RB, Todd RF 3rd. Beta 1 integrin expression on human small cell lung cancer cells. Cancer Res 1991;51:1065-1070.
29. Hartmann TN, Burger JA, Glodek A, Fujii N, Burger M. CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells. Oncogene 2005;24:4462-4471.